Alira Health Announces its Role as Strategic Advisor to Naxicap

Case Studies March 20, 2025

Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping

Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.

Patient Advocacy Patient Engagement Pharma

Case Studies March 6, 2025

Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement

A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).

Patient Centricity Pharma Rare Disease

Articles February 17, 2025

Rethinking Rare Disease Development: An Integrated, Patient Access-Driven Approach

Explore how biotech companies can succeed in rare disease by integrating development, commercialization, and patient access.

Patient Centricity Pharma Rare Disease

Articles February 11, 2025

From Diagnosis to Long-Term Care: Navigating the Rare Disease Journey

For Rare Disease Day, we spoke with patient engagement expert Luca Trentin on challenges faced by rare disease patients and how pharma can better understand their needs.

Patient Centricity Pharma Rare Disease

News January 8, 2025

Alira Health Launches the Global Payer Forum 2025 in Partnership with UPF Barcelona School of Management, NEWDIGS at Tufts Medical Center, and the University College of London

Alira Health is excited to announce the second year of the Global Payer Forum, a landmark educational initiative in partnership with distinguished academic institutions, UPF Barcelona(...)

Health Policy Market Access Pharma

Articles December 10, 2024

2024 Antibody-Drug Conjugates Landscape: Market Expansion, Innovations, and Strategic Acquisitions

Antibody-Drug Conjugates (ADCs) have emerged as a groundbreaking strategy in precision oncology, uniquely merging the specificity of antibodies with the potency of cytotoxic drugs.

ADC Antibody-Drug Conjugates Pharma

News December 2, 2024

Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market

This in-depth report explores emerging trends, competitive dynamics, market opportunities, cutting-edge innovations, and pivotal transactions shaping the antibody-drug conjugates (ADC) market.

ADC Antibody-Drug Conjugates Pharma